Search results for: Multi-Indication Medicines
Filter search results
Meeting the Challenges of Drug Development in 2022: Summary of OHE’s 50th Anniversary Conference
11 October 2012
…incentives for stratified medicine and for developing efficacy and safety data for more than one indication per product Use of electronic health records, registries and other patient databases to link…
New Research: Achieving Efficient Prices for Drugs in a Global Context
7 February 2013
…among other factors. Some features of current regulatory systems are inconsistent with achieving efficiency including, for example, external reference pricing and the inability to price by indication and/or patient subgroup….
Orphan Drugs Policies: A Suitable Case for Treatment
20 May 2014
…that incentives produce the intended consequences may require redefining ‘orphan disease’ or removing orphan status when a product achieves other, non-orphan, indications. ‘Probably the biggest concern about current policies for…
An Issues Panel: Developing Cost Effectiveness for Decision Making: What can be Learnt from “Value Based Pricing”?
29 July 2015
…better understanding of the preferences of the public and of patients. There was a need to invest in preference elicitation. Price flexibility by indication/subgroup and outcomes-based CED/PBRSA schemes are important…
Spotlight on OHE: Value Footprint of Oncology Treatments, Treating Obstructive Sleep Apnoea and Sources of Motivation in Health Care Organisations
4 August 2015
…use of new cancer drugs are often seen as being quite modest. Yet, many new cancer drugs have a therapeutic potential well beyond their initial indication. The objective of this…
Seminar Briefing: NHS Agency Staffing and the Impact of Recent Interventions
24 January 2018
…2015 + 150% + 100% + 55% Feb 2016 + 100% + 75% + 55% Apr 2016 + 55% + 55% + 55% Early indications suggest that the price caps…
Open Source Modelling: From Ideas to Action
16 May 2022
…widespread, despite indications of support from the research community. For this purpose, we surveyed ISPOR members. The results of our survey were recently published in Value in Health. Across 230…
Valuing Health at the End of Life: An Exploratory Preference Elicitation Study
1 December 2011
…the University of Sheffield. The results provide some indication of public support for a policy that assigns higher priority to the treatment of patients with short remaining life expectancy and…
Donor Investment Choices: Modeling the Value for Money of Investing in Product Development, Public Private Parnerships as Compared to Other Health Care and Non-Health Care Interventions
1 December 2006
…countries, these results look very promising. Conclusions The study provides a framework for assessing, and preliminary indications of, the cost-effectiveness of PD PPPs. Donors may wish to compare these results…